Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now X
Company Description (as filed with the SEC)
We are an autologous cell therapy company primarily focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs. Our lead orphan gene therapy program is in late stage pre-clinical development for the treatment of recessive dystrophic epidermolysis bullosa ("RDEB"). In addition to our gene therapy program, we are pursuing the medical application of azficel-T for vocal cord scarring using our proprietary autologous fibroblast technology. We are also in pre-clinical development for our second gene therapy program for linear scleroderma. Fibroblasts are the most common cell located in skin and connective tissue and are responsible for synthesizing extracellular matrix proteins that provide cellular structure and support. Fibroblasts are targeted to the localized environment of skin and connective tissue. ... More ...
Where does FCSC fit in the risk graph?
|Annual EPS Est:||$-0.8|
|Quarterly EPS Est:||-0.16|